Genome modification in human embryonic s
β
Toyoaki Tenzen; Filip Zembowicz; Chad A. Cowan
π
Article
π
2010
π
John Wiley and Sons
π
English
β 94 KB
π 1 views
## Abstract Induced pluripotent stem cell (iPSC) technology has emerged as the most promising method for generating patientβspecific human embryonic stem (ES) cells and adult stem cells (Takahashi et al., 2007, Cell 131:861β872; Wernig et al., 2007, Nature 448:318β324; Park et al., 2008, Nature 451